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Executive Summary
Post-Operative Nausea and Vomiting Risk Assessment and Prophylaxis
Patients who must undergo surgery with general anesthesia sometimes experience nausea
and vomiting. This is a potential side effect of general anesthesia and is termed post-operative
nausea and vomiting, or PONV. The screening process prior to surgery usually includes
questions regarding previous problems with PONV; however, this only applies to patients who
have had previous experiences with surgery and general anesthesia. Relying on a patients’
history of PONV alone to predict this unwanted side effect limits the providers’ ability to assess
and prophylactically treat PONV. Assessing for risk of PONV using a pre-operative risk
assessment tool can help to identify those who are at increased risk and potentially prevent
PONV. Incorporating a preoperative risk screening tool as well as a prophylactic protocol based
on risk would give providers a consistent process for screening patients without relying on a
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history of PONV. This process would ensure patients are treated with appropriate prophylaxis to
reduce incidence of PONV allowing for all patients to be screened rather than just in those who
have had previous surgery. PONV has many potential complications for patients, staff, and the
surgical facility. Even though PONV may be a side effect of anesthesia it may create an overall
negative experience for patients, which has the potential to affect the facility’s patient
satisfaction ratings.
Rationale for the Project
The incidence of PONV in surgical patients may be as high as 80% in those who are at
high risk, with a general incidence rate of 30% for all surgeries (Gan et al., 2014). PONV may
potentially lead to many unwanted physical and psychological complications for patients after
surgery. For some patients, PONV may only cause a small delay in discharge time; however, for
others, it could lead to life-threatening complications such as pulmonary aspiration, dehydration,
increased intercranial/intraocular pressures, and wound dehiscence (Squire & Spencer, 2018).
These Having surgery can be a source of stress for patients, however some patients fear PONV
more than the pain from surgery (Hambridge, 2013). Psychological complications from PONV
may include anxiety, distress, shame, embarrassment, and potentially fear of further surgeries.
Physical and psychological complications from PONV may create an overall negative
experience for patients, which has the potential to affect the facility’s overall patient satisfaction.
In addition to the physical and psychological complications for patients, PONV has the potential
to increase costs associated with surgery for the patient and the facility. Complications requiring
an overnight stay or a transfer to the hospital from the ambulatory center will increase costs for
patients, as well as the facility due to potential overtime for staff.
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From their review of literature, Squire and Spencer (2018) concluded that many factors
may potentially cause patients to be at increased risk for PONV, including type of anesthetic
used, type and length of surgical, history of motion sickness/PONV, gender, smoking status,
dehydration, and gastric distention. They explained that prophylactic treatment of PONV should
be dependent on patients’ risk; however, most patients who undergo surgery are generally treated
from PONV prophylactically.
Literature Synthesis
Databases were searched to find studies related to PONV, PONV risk assessment and
prophylaxis treatment of PONV. Of the studies found information was gathered related to risk
assessment tools used, and prophylaxis treatment guidelines. Risk assessment tools use evidencebased risk factors to determine the patient’s simplified risk score (SRS). The risk assessment
tools use factors such as female gender, history of PONV, history of motion sickness, nonsmoker, and postoperative opioid administration to calculate the SRS. The patients’ risk for
PONV is based on the number of risk factors present, therefore the higher the number of risk
factors the more likely the patient is to experience PONV (Hooper, 2015). Reduction in baseline
risk factors that can be altered is recommended by The Society for Ambulatory Anesthesia
(SAMBA). Risk factors that may be altered include avoidance of general anesthesia by using
regional anesthesia, preferential use of propofol infusions, avoidance of nitrous oxide, avoidance
of volatile anesthetics, minimization of peri-operative opioids, and adequate hydration (Gan et
al., 2014). The ability to identify patients who are at risk for PONV is helpful however, for this
tool to benefit the patient, and affect the incidence of PONV a prophylactic protocol is necessary
(Kappen et al.,2014). Five out of six studies recommend screening patients pre-operatively with
some form of SRS, and four out of six studies show a significant reduction in PONV with use of
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the SRS. Five out of six studies show that adding a prophylaxis protocol for providers to follow
based on the patients’ risk score showed a significant increase in administration of prophylactic
antiemetics in high-risk patients. These studies suggest assessing risk for PONV preoperatively
using a simplified risk score, along with a directive antiemetic prophylaxis protocol administered
by the anesthesia providers has the potential to significantly affect the incidence of PONV in
ambulatory surgical patients, as well as ensure prophylaxis treatment is initiated when patients
are found to be high risk for PONV (Kappen et al., 2015; Gan et al., 2014; Pym et al., 2018;
Smith et al., 2016; Tabrizi et al., 2018; Thomas et al., 2019).
Project Stakeholders
The addition of a pre-operative risk assessment for PONV would potentially benefit the
anesthesiologist, surgeons, and post anesthesia care unit (PACU) nurses. This group of doctors
and nurses would be the largest of the stakeholders for the proposed change. Data for incidence
of PONV at the center would be essential to obtain prior to the start of the project to help with
the education and rational of the project. The administrator, clinical director, and medical
director will be an important part of obtaining permission for completing the project. The
medical director in this case is an anesthesiologist and may potentially be a key stakeholder for
implementation. For this project, a directive prophylaxis protocol is needed and would have to be
written and approved by the administration team based on evidence from literature on
prophylaxis. Training and education would be needed for pre-operative nurses on the risk
assessment tool, as well as anesthesiologist for the directive prophylaxis protocol. The PACU
nurses would see the most benefit from the reduction in PONV and would-be great leaders for
this change.
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Implementation Plan
Postoperative nausea and vomiting (PONV) risk assessment should begin as the patient
is prepared for surgery. Patients will be screened for PONV using the Apfel risk assessment tool
to determine level of risk. The Apfel risk assessment is comprised of four questions: 1. Is the
patient of female gender? 2. Is the patient a non-smoker? 3. Does the patient have a history of
PONV/motion sickness? 4. Will the patient be receiving post-operative opioids? (Gan et al.,
2014). Each question with and answer of “yes”, will be equal to 1 point, with a possible total of
4 points and about 80% risk of PONV. This risk assessment will be completed and documented
during the first point of contact with the patient by phone when the pre-operative nurse calls to
gather pertinent health and mediation history from the patient. If the patient is unable to be
reached prior to the arrival at the center, the pre-operative nurse who prepares the patient for
surgery shall obtain the risk assessment. The risk assessment will be documented on a separate
form that will be part of the anesthesia hand off report. After a risk score has been calculated
for the patient, the nurse will then highlight the corresponding recommended intervention on
the prophylaxis portion of the risk assessment form. Here there will be a directive protocol for
prophylaxis interventions based on the patients’ risk score. This form will be placed with
anesthesia paperwork and the risk score and corresponding recommended prophylaxis will be
relayed during verbal report from the pre-operative nurse to the anesthesia provider. The
anesthesia provider and the pre-operative nurse shall both sign the form acknowledging the
information was relayed. If the provider chooses not to follow the directed prophylaxis, they
should complete, or circle the reason for choosing not to follow the recommendation.
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The form will become part of the patients record and will be used to document the
patient’s status postoperatively. The recovery nurse will document the presence of PONV in the
recovery area and any interventions during the recovery period related to PONV. The recovery
nurse will document delays in care due to PONV and complications related to PONV. This
information will be used to determine the incidence of PONV after implementation of the risk
assessment score and directive prophylaxis. To determine if using a risk assessment and
directive prophylaxis reduces the incidence of PONV data must be collected prior to
implementation. The postoperative nurses will audit charts using an audit form developed to
determine the incidence of PONV by determining the current incidence of PONV and collecting
data for 30 days prior to the implementation of the project.
Timetable/Flowchart
The project will be presented to the administration team at Baylor Surgicare Dallas where
it will need be approved for implementation prior to collecting data. Once approval is obtained,
staff from the post-anesthesia care unit will be introduced to the topic and a team will be formed.
This is an important step to ensure the project is successful. Once a team is in place data
collection will begin to find the current incidence of PONV at the facility. The goal is to collect
at least 30-45 days of data to get a baseline incidence rate. If it is possible to go back in the
records and collect data from previous patients this would be ideal to gain a larger preimplementation incidence rate of PONV. During the data collection by the project team,
education of the staff about PONV and the rational for the project would begin. Education for all
nurses would be completed by a member of the project team. The anesthesia providers would be
given information about the project and the coming risk assessment tool and directive
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prophylaxis as part of the education roll out. Once staff have received education the SRS and
prophylaxis protocol will be implemented in the pre-operative area, and the anesthesia providers
will have access to the directive prophylaxis protocol by email as well as the details of the
project. The goal is to collect data for 1 month and then revisit with the team and discuss the
implementation process to ensure barriers or process issues are addressed. At the 1-month mark
results of the project would determine if changes need to be made to the process. Ideally the
project would last for at least 3 months to see if the process was working to reduce the incidence
of PONV. Assessment of data collected on incidence of PONV before and after the project was
implemented will be reviewed. The data will need to show a change in the incidence of PONV,
as well as the increase in use of the directive prophylaxis protocol based on risk. Data will be
gathered from the project, as well as discussions with the team for an overall evaluation of how
well the plan was implemented. Since the change project is unable to be implemented staff will
be educated about PONV. The intent is to increase awareness of PONV potential complications,
known risk factors, and identification of patients who would potentially benefit from
prophylaxis.
Project Phases
Approval from administration team
Meeting with staff to form project team
Begin PONV incidence data collection
Meet with team to write SRS, Directive prophylaxis/approval/ data collection tool
Education for Staff on Pre-op assessment/prophylaxis
Implement SRS/Prophylaxis directive
Team meeting discuss implementation process/barriers
Final team meeting/ data collection ends
Data analysis/discuss issues with change implementation/refine process
Complete project

Timeline
By January 1, 2021
Januar y 4
January 6
January 6-11
January 12
February 15
February 22
March 26
March 26- April 2
April 26
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Data Collection Methods
The incidence of PONV in ambulatory surgical patients at Baylor Scott and White
Surgicare Dallas would be measured prior to beginning the project. This data will then be
compared to the data collected after the implementation of a risk assessment tool to determine
the patient’s risk for PONV, as well as a directive prophylaxis protocol to be used by the
anesthesia providers. Risk assessment tools use evidence-based risk factors to determine the
patient’s simplified risk score (SRS). The risk assessment tools use factors such as female
gender, history of PONV, history of motion sickness, non-smoker, and postoperative opioid
administration to calculate the SRS. The patients’ risk for PONV is based on the number of risk
factors present, therefore the higher the number of risk factors the more likely the patient is to
experience PONV (Hooper, 2015). The ability to identify patients who are at risk for PONV is
helpful however, for this tool to benefit the patient, and affect the incidence of PONV a
prophylactic protocol is necessary (Kappen et al.,2014). Once both tools are implemented the
incidence rates of PONV in the ambulatory patients would again be measured to determine if
there was any change in the incidence rates of PONV with use of the tools.
Within the data collected the use of the directive prophylaxis protocol would also be key
to determine if the recommendations based on the patient’s risk score were followed through
with prophylaxis. This would help to determine if the protocols created for prophylaxis are
effective against PONV, and ensure they are being utilized with high-risk patients. A team would
also be created to debrief with anesthesia providers using the directive prophylaxis to gather
feedback about the protocol and determine if there need to be changes made based on use and
effect on PONV incidence. Once the data is collected and analyzed to see effect on incidence of
PONV the project will then need to be reviewed for potential changes with the key stakeholders.
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The data will need to show a change in the incidence of PONV, as well as the use of the
directive prophylaxis protocol based on risk. Data will be gathered from the project, as well as
discussions with the team for an overall evaluation of how well the plan was implemented. If the
change project is unable to be implemented staff will be educated about PONV. The intent would
be to increase awareness of PONV potential complications, known risk factors, and identification
of patients who would potentially benefit from prophylaxis.
Cost/Benefit Discussion
The costs associated with this plan should be minimal, at most it would be an increase
use of antiemetic medications, which could potentially be offset by decreased
complications/recovery time. The benefit of reducing incidence of PONV would be to decrease
the amount of overtime for the recovery department. When patients experience PONV recovery
time is increased, and this has a potential to increase workload for the recovery nurses. With
more time spent caring for patients who are nauseated or vomiting, this can take time away from
other patients as well as increase the time it takes to discharge other patients the nurse is caring
for. If PONV incidence is reduced the workflow for nurses can be maintained which will ensure
that patients discharge time is not delayed and staffing is appropriately maintained for the day.
Discussion of Results
PONV will continue to be a problem in surgical patients. Ambulatory centers such as
Baylor Surgicare could benefit from ensuring all steps are taken to reduce the incidence of
PONV. At this time, the project was not able to be implemented however, I do think it brought
awareness to the issue and has potential for implementation in the future. This time has been a
struggle for staff and the center while trying to recover from the time lost during the furlough of
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staff and the center being closed for operation for over a month during the pandemic. The center
is also in the middle of a transition from operating out of two separate facilities and now has
combined both centers of employees and procedures to one building. This has been a time of
challenge for the staff and administration and unfortunately not an ideal time for an
implementation project. When the time is appropriate, and data collection of the incidence of
PONV can be obtained, it is my belief findings will be significant enough to warrant an
exploration of current practices. At that time the evidence of PONV risk assessments can be
added to the pre-operative process and a prophylactic protocol can be developed and
implemented, and I feel the findings will support a need for practice change.
Conclusions/Recommendations
Patients who experience PONV have the potential to experience life-threatening physical
and psychological complications. PONV may also create an increase in the costs of care for
patients as well as facilities by prolonging recovery time. Understanding that PONV is not only a
nuisance for patients but can even lead to life threatening complications such as aspiration and
wound dehiscence, it becomes a very hard topic to ignore. Using a risk assessment tool to
identify patients at risk for PONV along with the use of a directive prophylactic treatment
protocol has the potential to reduce the incidence of PONV. Evidence is clear patients do not
want to experience PONV as well as the surgeons, anesthesiologist, and any nurses responsible
for care want to do what is possible to prevent it from occurring. Following evidence-based
practice for prevention of PONV may help providers to identify those who are at risk and
decrease the chances of occurrence in some cases. Currently in the ambulatory surgery center
there are no specific guidelines or directives that dictate what prophylaxis medications a patient
may get, and there is no specific tool or risk assessment used to identify patients who are at risk
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for PONV. All methods used to identify and assess need for prophylaxis and even what type of
prophylaxis is left up to the anesthesiologist at this time. Following systematic process using
evidence-based practice to identify risks and treat with the appropriate prophylaxis has the
potential to reduce the incidence of PONV according to Gan et al., 2014. With this the
conclusion of the data collected it seems PONV incidence rates should be explored as well as a
process implemented to ensure patients are screened for potential risk and treated accordingly.
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Appendix A: Evaluation Table

PICOT Question: In ambulatory surgical patients receiving general anesthesia (P) how does utilizing a pre-operative risk
assessment tool for post-operative nausea and vomiting along with a directive prophylaxis protocol (I) compared to no risk
assessment tool or protocol (C) affect the incidence of post-operative nausea and vomiting (O) in the first twenty-four hours after
surgery (T)?
PICOT Question Type (Circle): Intervention Etiology

Diagnosis or Diagnostic Test

Prognosis/Prediction Meaning

Caveats
1) The only studies you should put in these tables are the ones that you know answer your question after you have done rapid
critical appraisal (i.e., the keeper studies)
2) Include APA reference
3) Use abbreviations & create a legend for readers & yourself
4) Keep your descriptions brief – there should be NO complete sentences
5) This evaluation is for the purpose of knowing your studies to synthesize.
Place your APA Reference here (Use correct APA reference format including the hanging indentation):
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Appendix A: Continued

Citation: (i.e.,
author(s),
date of
publication,
& title)
Author, Year,
Title

Conceptual
Framework
Theoretical
basis for
study
Qualitative
Tradition

Design/
Method

Sample/
Setting
Number,
Characteristi
cs,
Attrition rate
& why?

Major
Variables
Studied and
Their
Definitions
Independent
variables
(e.g., IV1 =
IV2 =)
Dependent
variables (e.g.,
DV = )

Pym, et al.
(2018). The
Effect of a
Multifacete
d
Postoperati
ve Nausea
and
Vomiting
Reduction
Strategy on
Prophylaxis
Administrat
ion
Amongst
Higher-Risk
Adult
Surgical
Patients

None
stated

Quant
itativ
e;
Pre/postinterv
entio
n
cohor
t
study

N=1102
Mean age
53
60% Male
40%
Female
Mean age
52
60% male
40%femal
e

IV: use of
prophylacti
c
antiemetics
for patients
at moderate
or high risk
of PONV

Measurement of
Major Variables
What scales were
used to measure
the outcome
variables (e.g.,
name of scale,
author, reliability
info [e.g.,
Cronbach
alphas])

Data
Analysis
What stats
were used
to answer
the
clinical
question
(i.e., all
stats do
not need
to be put
into the
table)

Evidence
based locally
developed
PONV
guideline;
PONV risk
classification

Χ2

DV: Use of
PONV
prophylaxis
guidelines

Study Findings
Statistical findings or
qualitative findings (i.e.,
for every statistical test
you have in the data
analysis column, you
should have a finding)

Consistent
administration of
guideline
prophylaxis
(p=0.004) post
Intervention
(p=0.001)-post
Intervention
Reduction of
PACU length of
stay In the highrisk group postintervention
(p=0.032)

Attrition
ratenone

Appendix A: Continued

Strength of the Evidence (i.e., level of evidence
+ quality [study strengths and weaknesses])
• Strengths and limitations of the study
• Risk or harm if study intervention or
findings implemented
• Feasibility of use in your practice
• Remember: level of evidence (See Melnyk
& Finout-Overholt, pp. 32-33) + quality of
evidence = strength of evidence & confidence
to act
• Use the USPSTF grading schema
http://www.ahrq.gov/clinic/3rduspstf/ratings.h
tm

Limitations
-PONV rates were only collected during
PACU stay no follow up after PACU
discharge which could possibly have missed
some delayed PONV
-no assessment done to show that the
providers reviewed the data prior to
intervention
Strengths
-Increase In provider administration of
antiemetics In high risk patients
-decreased pacu length of stay due to
decreased PONV with Implementation
Feasible In practice with Improved
Implementation technique
Low risk of harm
Level of evidence: 4
USPSTF: Grade B
Level of certainty: low

PONV RISK ASSESSMENT
None
Kappen,
Stated
et al.
(2015).
Impact of
adding
therapeut
ic
recomme
ndations
to risk
assessme
nts from
a
predictio
n model
for
postoper
ative
nausea
and
vomiting

Quant
itativ
e;
prosp
ective
befor
e and
after
cohor
t
study

20
University
Medical
Center
Utrecht,
Netherlan
ds
(N= 1480)
Care as
usual
(n=1022)
Interventi
on group
(n= 458)
100%
Female
Mean age:
Care as
usual=52
Interventi
on
group=54
Attrittion:
none

IV1= use
of DDSP
for AP
IV2=
administra
tion of risk
dependen
t PONV
prophylaxi
s
DV=
incidence
of PONV,

The
OR/CI
implementat
ion
prediction
model for
PONV,
unsure of
R2/CI
reliability
developed at
a university
hospital in
the
Netherlands,
externally
validated

PONV Incidence
during
Intervention
period compared
to care-as-usual
(OR: 0.60, 95%
CI: 0.43-0.83)
Administration of
additional
antiemetics as
directed 0.49
(95% CI: 0.410.58)

Limitations
-small sample size
-decisions to give medications
based on the recommended
model may not have been
superior to the care-as -usual
phase
-adherence to the therapeutic
recommendations was not 100%
-feasible for use In practice
Low risk of harm
Level of evidence: 4
USPSTF: Grade B
Level of certainty: low
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Smith, et al.
(2016).
Improving
the quality
of postanesthesia
care: An
evidence
based
initiative to
decrease
the
incidence
of
postoperati
ve nausea
and
vomiting in
the postanesthesia
care unit.
Perioperati
ve Care and
Operating
Room
Manageme
nt(4) 12-16.

None
Stated

Quant
itative
;
Qualit
y
impro
veme
nt,
preand
postinterv
ention

N=4907
historical
group
n =3768
Implement
ation group
n = 1139

adult
elective
surgery
patients
with GA,
admitted
to PACU

York, PA,
USA

IV=
preoperati
ve PONV
risk
screening
and
targeted
prophylaxis

DV=
Incidence
of
postoperati
ve nausea
and
vomiting

Apfel
simplified
risk score 0-4

Χ2

OR/CI

Incidence of PONV
significantly lower in
the postimplementation
sample (p=0.000054)
Both genders had
decreased Incidence
PONV
males: (Χ2= 4.52, p =
0.03)
females: (Χ2= 14.4, p
= 0.00014)
Incidence of PONV
implementation
group: 0.13 (0.10 to
0.16)
Implementation
sample:
0.44 (0.22 to 0.8880)

Limitations
-Design of the study- difficult to extract
data from health record if not noted or
addressed. Only interpretation of
patient’s health record since some
criteria was not specifically addressed.
-limitation on time frame PONV
present since only monitored in pacu
and discharge, not on inpatients.
-historical sample was unable to obtain
some information that is needed to
complete the risk assessment like
motion sickness.
- Historical sample only able to gather
PONV incidence based on medications
given, not an interaction or question of
presence of PONV
Low risk of harm
Level of evidence: 6
USPSTF: Grade B

Attrition:
none

Level of certainty : low
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Tabrizi, et
al. (2019).
Implement
ation of
postoperati
ve nausea
and
vomiting
guidelines
for female
adult
patients
undergoing
anesthesia
during
gynecologic
and breast
surgery in
an
ambulatory
setting.
Journal of
PeriAnesthe
sia Nursing.
Advance
online
publication.
http://doi.o
rg10.1016/j
.jopan.2018
.10.006

None
Stated

Quant
itative
;
Pre/p
ost
imple
menta
tion
qualit
y
impro
veme
nt
projec
t

N= 294
Female
mean age
45,
GYN/breast
surgery
with
general or
MAC
anesthesia
preimplem
entn = 147
postimple
ment n
=147
major
multicamp
us teaching
hospital in
northeaste
rn U.S.
Attrition:
none

IV=
implementa
tion of
evidence
based PONV
guideline
DV1=
Anesthesia
compliance
with
documentati
on of Apfel
risk
assessment
score
DV2=
Incidence of
PONV in
female
patients
undergoing
GYN or
breast
surgery in
an
ambulatory
setting

Convenience
sample of
retrospective
chart reviews
from
electronic
health
record.
PONV
guidelines
created using
institutional
guidelines,
literature
review, input
from staff
Apfel risk
score: Postop opioids,
non-smoker;
female ;
history of
PONV/MS

Χ2

Incidence of PONV
significantly
decreased int the
posimplementation
period p= .009

statistically significant evidence

Anesthesia
providers charting
the correct Apfel
score significant
increase

Limitations-manual chart
review/data collection, small
sample size, only specific surgery
type, limited staff education

p= 0.019

Significant
reduction in
incidence of PONV
with general
anesthesia 21% to
10%

strengths-able to successfully
implement risk stratification and
targeted prophylaxis that was
easily adopted by staff and
providers

Low risk of harm
Level of evidence: 6

USPSTF: Grade B

Level of certainty: low
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Thomas et
al., (2019).
Preoperativ
e risk
assessment
to guide
prophylaxis
and reduce
the
incidence
of
postoperati
ve nausea
and
vomiting. J
ournal of
PeriAnesth
esia
Nursing, 34
(1), 74-85.
http://doi.or
g10.1016/j.j
opan.2018.
02.007

None
stated

Qualit
y
impro
veme
nt
projec
t;
retros
pectiv
e
pre/p
ost
imple
menta
tion
qualit
y
impro
veme
nt
projec
t

N=316
Female
mean age
range 4042 ,
gynecolog
ic surgery,
N= 316,
preimple
menation
n= 164 ,
postimple
mentation
n=152

Communit
y hospital
in the U.S.
Attrition:
none

IV: Use of
PONV
prophylaxis
protocol

DV:
prophylaxis
and
incidence
of PONV

Data was
collected using
retrospective
chart reviews.
PONV risk
assessment
tool to guide
prophylaxis
based on risk
using six
predictors of
PONV: general
anesthesia,
female,
<50years of
age,
nonsmoking
status, history
of PONV or
motion
sickness, and
anticipated
postoperative
opioid
administration

M

t

Increase in the total
number of
prophylactic
antiemetics
administered in the
moderate-risk and
high-risk categories
from
preimplementation
3.64 to
postimplementation
4.07
(t = 3.96; df = 298.9;
P < .001) Significant
increase in
postimplementation
for antiemetics
administered
Incidence of PONV
decreased in the
postimplemenation
period

Χ2

Reduction 79%
preimplementation
to 29%
postimplemenation

Strengths: Risk assessment tool
identified moderate to high risk
patients and helped to increase
prophylaxis
Limitations: small sample size,
limited to gynecologic surgery, and
female only patients. Female
gender is an independent risk
factor for PONV. Compliance from
providers who are responsible for
administering prophylaxis
Risk: None stated
Feasibility: use to assess risk for
PONV in surgical patients.
Level of evidence: 6
USPSTF: Grade B
Level of certainty: low
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Gan et al.,
(2014)
Consensus
guidelines
for the
manageme
nt of
postoperati
ve nausea
and
vomiting.
Anesthesia
&
Analgesia,
118(1), 85113.
http://doi.o
rg10.1213/
ANE.00000
000000000
002

None
stated

Qualit
ative
Syste
matic
literat
ure
revie
w

N= 2604
n= 564
risk
assessme
nt

IV: use of
risk
assessment
tool

n= 549
risk
reduction

IV: Use of
PONV
prophylaxis
protocol

n=171
PONV
protocols
n= 433
prophylaxi
s
n=567
treatment
effectiven
ess
n= 320
nonpharm
acological
/alternativ
e therapy

DV:
prophylaxis
protocol
use and
assessment
of risk

Literature was
searched using
6 different
topics:
Algorithms,
prophylaxis
treatment
effectiveness,
nonpharmacol
ogical or
alternative
therapy, risk
assessment,
risk reduction

t

Identification of risk
factors that increase
risk of PONV;
<50y/o, type of
procedure, opioid
administration,
female gender,
history of motion
sickness, duration of
anesthesia, use of
volatile anesthetics,
and nitrous oxide.

Strengths:

Reducing risk factors
to reduce incidence
of PONV

USPSTF: Grade B

Administration of 1-2
prophylactic
interventions in
moderate risk
patients
Administration of
prophylactic therapy
with >=2 in high risk
patients

Limitations: inadequate literature.
Unable to assess if relationship
between interventions and
outcomes.
Risk: None stated
Feasibility: use for risk assessment
and treatment prophylaxis
Level of evidence: 1

Level of certainty: moderate
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Gecit, S.,
&
Ozbayir, T.
(2020).
Evaluation
of
preoperati
ve risk
assessmen
t and
postopera
tive
nausea
and
vomiting:
Importanc
e for
nurses. Jo
urnal of
PeriAnesth
esia
Nursing, 3
5(6), 625629. https:
//doi.org/
10.1016/j.j
opan.2020
.04.006

None
stated

Qualit
ative
Descri
ptive
Study

N= 242
n= 137
men
n= 105
women

IV: Use of
Apfel and
Koivuranta
risk scoring
systemin
surgical
patients

DV: Early
detection
and
prevention
of PONV

Surgical
patients
who had
surgery
were
evaluate
d
through
forms
from
medical
records
with
demogra
phic
informati
on and
risk
scores
for ponv.

Strengths:
Χ2

Apfel and Koivuranta
both showed
significant difference
between use of the
scoring systems and
PONV

Limitations: Small sample size
Risk: None stated
Feasibility: use for risk assessment
and treatment prophylaxis
Level of evidence: 1
USPSTF: Grade B
Level of certainty: moderate
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Apfel, C. C.,
Heidrich, F.
M., JukarRao, S.,
Jalota, L.,
Hornuss, C.,
Whelan, R.
P.,
Zhang, K., &
Cakmakkay
a, O. S.
(2012).
Evidencebased
analysis of
risk factors
for
postoperati
ve nausea
and
vomiting. B
ritish
Journal of
Anaesthesi
a, 109(5),
742753. https:
//doi.org/
10.1093/bj
a/aes276

None
stated

Qualit
ative

N= 22
IV:
individual
predictors
for risk of
PONV

DV: Overall
accurate
points for
each
individual
predictor

Literature
was
searched
using 3
different
database
s.
Reviewe
d
systemat
ically for
individua
l
predictor
accurate
point
predictio
n of
PONV

I2

Risk factors:

Strengths:

Patient =46

Limitations: none stated

Anesthesia= 58

Risk: None stated

Surgery= 70

Feasibility: use for risk assessment
and treatment prophylaxis
Level of evidence: 1
USPSTF: Grade B
Level of certainty: moderate
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Smith, C. A
., & RuthSahd, L.
(2016).
Reducing
the
incidence
of
postoperati
ve nausea
and
vomiting
begins with
risk
screening:
An
evaluation
of the
evidence. J
ournal of
PeriAnesth
esia
Nursing, 31
(2), 158171. https://
doi.org/10.
1016/j.jopa
n.2015.03.0
11

None
stated

Qualit
ative

N= 37
IV: identify
PONV risk
factors in
patients

Literature
was
searched
using 4
different
database
s.

Strengths:
Limitations: English language only

OR
Volatile anesthetics =
1.82

Risk: None stated

Age= 0.88

Feasibility: use for risk assessment
and treatment prophylaxis

Female gender= 2.57

DV:
reduction
in
incidence
of PONV

Level of evidence: 3
USPSTF: Grade B
Level of certainty: moderate
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Wu, Y. H.,
Sun, H. S.,
Wang, S.
T., &
Tseng, C.
A. (2015).
Applicabil
ity of risk
scores for
postoperat
ive nausea
and
vomiting
in a
Taiwanese
population
undergoin
g general
anaesthesi
a. Anaesth
esia and
Intensive
Care, 43(4
), 473478. https:
//doi.org/1
0.1177/03
10057x15
04300409

None
stated

Qualit
ative

N= 992
Female579
Male-413

IV: Scoring
system for
PONV risk

DV:
Developme
nt of a new
scoring
system
using
Taiwanese
data

Observational
data collected
from 1000 bed
tertiary
hospital for
patients
receiving
general
anesthesia

Strengths:

t

Female p= <0.001

History of motion
sickness/ponv p=
0.004

Limitations: only enrolled
Taiwanese patients from one
tertiary hospital in Taiwan. Patients
were scheduled for major surgery,
may not apply to younger
population patients were
scheduled for longer surgeries and
endotracheal intubation.
Risk: None stated
Feasibility: use for risk assessment
and treatment prophylaxis
Level of evidence: 1
USPSTF: Grade B
Level of certainty: moderate
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Sawatzky, None
J. V.,
stated
Rivet, M.,
Ariano, R.
E.,
Hiebert, B.
,&
Arora, R. C
. (2014).
Postoperative
nausea
and
vomiting
in the
cardiac
surgery
population
: Who is at
risk? Heart
&
Lung, 43(6
), 550554. https:
//doi.org/
10.1016/j.
hrtlng.201
4.07.002

Qualit
ative

N= 150

Cardiac
patients
IV: Scoring
undergoing
system for CABG,
PONV risk
isolated
valve, or
combined
OR
procedure in
tertiary
DV:
center in
Developme
Canada.
nt of a new
scoring
system for
cardiac
surgery
patients

Strengths:
Limitations: retrospective design
small sample size
HX of PONV= 3.54

Risk: None stated

Female =4.11

Feasibility: use for risk assessment
and treatment prophylaxis

Non-smoker =3.31
Extubated on
admission to CSICU=
3.57
Intra operative
steroid use= 3.23

Level of evidence: 1
USPSTF: Grade B
Level of certainty: moderate

PONV RISK ASSESSMENT

30
Appendix A: Continued

Chau, D.,
Reddy, A.,
Breheny, P.,
Young, A.,
Ashford, E.,
Song, M.,
Zhang, C.,
Taylor, T.,
Younes, A.,
&
Vazifedan, T
. (2017).
Revisiting
the
applicability
of adult early
postoperative
nausea and
vomiting risk
factors for
the paediatric
patient: A
prospective
study using
cotinine
levels in
children
undergoing
adenotonsille
ctomies. Indi
an Journal of
Anaesthesia,
61(12),
964. https://d
oi.org/10.410
3/ija.ija_303
_17

None
stated

Qualit
ative

N= 200
IV: Adult
PONV risk
factors can
be applied
to pediatric
patients

Patients who
were
scheduled for
adenotonsillec
tomies at a
outpatient
surgical facility

Strengths:

Family HX of PONV =
P < 0.01

OR

Hx of motion sickness
P = 0.02

Limitations: use of dexamethasone,
limited to one type of procedure,
and protocolized anesthesia
techniques
Risk: None stated
Feasibility: use for risk assessment
and treatment prophylaxis
Level of evidence: 1

DV: PONV
risk factors
for
pediatric
patients

USPSTF: Grade B
Level of certainty: moderate
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Legend:
PONV- Post operative nausea and vomiting
PACU- Post anesthesia care unit
MS- Motion sickness
GA- General anesthesia
M- mean
Χ2 – chi square test
t- t-test
OR- Odds ratio
CI- confidence interval
R2- regression analysis
DDSP for AP- directive decision support tool for antiemetic prophylaxis
***Prompts for each column – please do not repeat the headings, just provide the data
Used with permission, © 2007 Fineout-Overholt
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Appendix C: Apfel risk assessment tool Directive prophylaxis protocol

PONV prophylaxis guidelines
Determine the number of risk factors for PONV using risk score from Apfel.

Risk Factors
Female Gender
Non-Smoker
History of PONV/Motion sickness
Post-operative opioids
Risk Score Total

Points
1
1
1
1
0-4

Prophylaxis bases on risk score total __________
Risk Score
0
1

Prevalence of
PONV
9%
20%

Prophylaxis: # of
antiemetics
0-1
1

2

39%

2

3

60%

3

4

78%

4

Examples
Ondansetron 4mg
Ondansetron 4mg
± Dexamethasone 4mg
Ondansetron 4mg
+ Dexamethasone 4mg
+ Propofol infusion
Ondansetron 4mg
+ Dexamethasone 4mg
+ Propofol
± Scopolamine patch
Ondansetron 4mg
+ Dexamethasone 4mg
+ Propofol infusion
+ Scopolamine patch

**Drug Combinations should be with drugs that have different mechanisms of
action.

